researcher at microscope
  • Article
  • Oct 11 2018

XLerateHealth LLC, a Louisville-based health care technology accelerator that focuses on startups and commercialization, will join forces with a consortium of 24 academic institutions led by UK, in partnership with UofL and West Virginia University.

Recent News

Series Spotlight People Behind Our Research

Why do we want you to meet our researchers?

The scientists and scholars at the University of Kentucky are remarkable people. Some of them have a very personal connection to field they have chosen: a family member battling addiction or disease. Some of them began their journey based on curiosity. A drive to find out why the world works the way it does.

What they all have in common is a passion to ignite progress and partner across fields and with communities to confront, head on, the most profound challenges. Research can do that, and our researchers tell you why and how.

View Series


  • Podcast
  • Feb 01 2018

Hear how William Stoops chose drug abuse research, why mentoring is one of his favorite parts of his job, and why he sees the chance to do NIH-funded research as a privilege.


    • Sep 24 2018

    The research building — funded half from the state of Kentucky and half from university resources, including private gifts — will house multidisciplinary research teams focusing on the Commonwealth’s most dire health disparities including cancer, diabetes and obesity, cardiovascular diseases and stroke and substance abuse.

    • Sep 21 2018

    A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.

    • Sep 17 2018

    This is the largest fundraising campaign in Kentucky's history. It will focus on funding more student scholarships and growing UK's endowment to continue support for providing a world-class education and essential research to address the state's most pressing challenges.

    • Sep 12 2018

    With funds from NIH, Barbara Nikolajczyk is tracking the trajectory of type 2 diabetes. She's following metabolically healthy people as they naturally progress to diabetes, looking for potential drug targets along the way.